
Paul-Ehrlich-Institut Approves First COVID-19 Therapy Study with Convalescent Plasma
The Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, has granted approval for the first clinical trial with COVID-19 convalescent plasma (CAPSID) in Germany. The aim […]